Brown Scaly Spots on Forehead: Evaluation and Treatment
The most likely diagnosis is actinic keratosis (AK), and you should initiate field-directed treatment with topical 5-fluorouracil, imiquimod, or tirbanibulin after confirming the diagnosis clinically or with biopsy if there is any concern for invasive squamous cell carcinoma. 1, 2, 3
Initial Evaluation
Key diagnostic features to assess:
- Texture and thickness: Rough, scaly texture with adherent scale on sun-exposed forehead suggests AK
- Warning signs requiring biopsy: Bleeding, pain, rapid growth, or palpable thickness when pinched between fingers indicate possible invasive SCC and warrant 2-week urgent referral 1
- Distribution: Multiple lesions in sun-exposed areas (forehead, scalp, face, dorsal hands) support AK diagnosis
- Patient risk factors: Fair skin, chronic UV exposure, immunosuppression 1
Critical distinction: While seborrheic keratosis can also present as brown scaly lesions, these typically have a "stuck-on" waxy appearance rather than the rough, sandpaper-like texture of AK 4, 5. Seborrheic dermatitis presents with greasy (not dry) scales and erythema, often in the nasolabial folds 6.
When to Refer vs. Treat in Primary Care
Refer urgently (2-week cancer pathway) if: 1
- Lesion is bleeding, painful, or has palpable substance
- Concern for invasive SCC
- Failure to respond to standard treatment
- Immunosuppressed patients with multiple lesions
Primary care management is appropriate for: 1
- Thin, asymptomatic AKs without concerning features
- Patients with fewer than 10 lesions
- No history of skin cancer
Treatment Approach
Field-Directed Treatment (Preferred for Multiple Lesions on Forehead)
First-line topical options (all have strong evidence): 1, 2, 3
5-Fluorouracil cream: Apply twice daily for 2-6 weeks
Imiquimod 5% cream: 3 times weekly for 16 weeks
Tirbanibulin 1% ointment: Once daily for 5 consecutive days (NEW - strongest recent evidence)
Diclofenac 3% gel: Twice daily for 60-90 days
Lesion-Directed Treatment (For Few Isolated Lesions)
Cryosurgery (liquid nitrogen): 1, 7
- 75-85% complete response rate
- Duration matters: <5 seconds = 39% cure; >20 seconds = 83% cure
- Expect soreness, blistering, and potential pigmentary changes
- Cannot confirm histology
When lesions fail topical therapy: 1
- Perform curettage with 2-3 cycles to obtain histology
- Consider deep shave or formal excision if SCC cannot be excluded
- Curettage alone may make it difficult to assess dermal invasion
Critical Management Points
Define the treatment field with the patient before starting topical therapy to ensure they anticipate and tolerate side-effects 1. For forehead lesions, clearly mark the area to be treated.
Sun protection is mandatory for all patients - this is non-negotiable regardless of treatment choice 1, 2. Twice-daily sunscreen application reduces new AK development 7.
Patients with ≥10 AKs have 3-fold higher risk of SCC and warrant more aggressive treatment and shorter follow-up intervals 1.
Common Pitfalls to Avoid
- Do not use destructive therapies (cryotherapy, curettage, laser) without histology if there is any concern for invasive SCC - you need tissue diagnosis 1
- Hyperkeratotic lesions that fail to respond to topical therapy require biopsy - they may harbor invasive SCC 1
- Do not assume all brown scaly lesions are benign - always assess for bleeding, pain, and rapid growth 1
- Pretreatment with 5% salicylic acid ointment can improve outcomes by removing overlying keratin before applying 5-FU 7
The evidence strongly supports field treatment for forehead AKs given the likelihood of subclinical actinic damage in adjacent skin. 1 While individual lesion destruction may clear visible lesions, it does not address the field of sun-damaged skin that will generate new AKs.